Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.

ABSTRACT:

Background & aims

Hepatocellular carcinoma (HCC) is the second most common cause of cancer deaths worldwide. The global HCC BRIDGE study was a multiregional, large-scale, longitudinal cohort study undertaken to improve understanding of real-life management of patients with HCC, from diagnosis to death.

Methods

Data were collected retrospectively from January 2005 to September 2012 by chart reviews of eligible patients newly diagnosed with HCC at participating institutions.

Results

Forty-two sites in 14 countries contributed final data for 18 031 patients. Asia accounted for 67% of patients, Europe for 20% and North America for 13%. As expected, the most common risk factor was hepatitis C virus in North America, Europe and Japan, and hepatitis B virus in China, South K

SUBMITTER: Park JW 

PROVIDER: S-EPMC4691343 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature